Your browser doesn't support javascript.
loading
How PET-CT is Changing the Management of Non-metastatic Castration-resistant Prostate Cancer?: Comment la TEP-TDM Peut Modifier la Prise en Charge du Cancer de la Prostate Non Métastatique Résistant à la Castration ?
Baboudjian, M; Gauthé, M; Barret, E; Brureau, L; Rocchi, P; Créhange, G; Dariane, C; Fiard, G; Fromont, G; Beauval, J-B; Mathieu, R; Renard-Penna, R; Roubaud, G; Ruffion, A; Sargos, P; Rouprêt, M; Ploussard, G.
Afiliação
  • Baboudjian M; Department of Urology, APHM, North Academic Hospital, Marseille, France; Marseille Cancerology Research Center-Inserm UMR 1068, Aix-Marseille Université U105-CNRS UMR 7258, CERIMED Bât.10A - 27 Boulevard Jean Moulin - 13005 Marseille, France; Department of Urology, Fundació Puigvert, Autonoma Univer
  • Gauthé M; Department of Nuclear Medicine, Scintep - Institut Daniel Hollard, Grenoble, France.
  • Barret E; Department of Urology, Institut Mutualiste Montsouris, Paris, France.
  • Brureau L; Department of Urology, CHU de Pointe-à-Pitre, University of Antilles, University of Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, F-97110 Pointe-à-Pitre, France.
  • Rocchi P; Marseille Cancerology Research Center-Inserm UMR 1068, Aix-Marseille Université U105-CNRS UMR 7258, CERIMED Bât.10A - 27 Boulevard Jean Moulin - 13005 Marseille, France.
  • Créhange G; Department of Radiotherapy, Institut Curie, Paris, France.
  • Dariane C; Department of Urology, Hôpital européen Georges-Pompidou, APHP, Paris - Paris University - U1151 Inserm-INEM, Necker, Paris, France.
  • Fiard G; Department of Urology, Grenoble Alpes University Hospital, Université Grenoble Alpes, CNRS, Grenoble INP, TIMC-IMAG, Grenoble, France.
  • Fromont G; Department of Pathology, CHRU Tours, Tours, France.
  • Beauval JB; Department of Urology, La Croix du Sud Hôpital, Quint Fonsegrives, France.
  • Mathieu R; Department of Urology, CHU Rennes, Rennes, France.
  • Renard-Penna R; Sorbonne University, AP-HP, Radiology, Pitie-Salpetriere Hospital, F-75013 Paris, France.
  • Roubaud G; Department of Medical Oncology, Institut Bergonié, 33000 Bordeaux, France.
  • Ruffion A; Service d'urologie Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France; Equipe 2 - Centre d'Innovation en cancérologie de Lyon (EA 3738 CICLY) - Faculté de médecine Lyon Sud - Université Lyon 1.
  • Sargos P; Department of Radiotherapy, Institut Bergonié, 33000 Bordeaux, France.
  • Rouprêt M; Sorbonne University, GRC 5 Predictive Onco-Uro, AP-HP, Urology, Pitie-Salpetriere Hospital, F-75013 Paris, France.
  • Ploussard G; Department of Urology, La Croix du Sud Hôpital, Quint Fonsegrives, France; Department of Urology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France On behalf of the Prostate Cancer Committee of the Association Française d'Urologie (CC-AFU).
Prog Urol ; 32(6S1): 6S43-6S53, 2022 Jun.
Article em En | MEDLINE | ID: mdl-36719646
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies / Screening_studies Limite: Humans / Male Idioma: En Revista: Prog Urol Assunto da revista: UROLOGIA Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies / Screening_studies Limite: Humans / Male Idioma: En Revista: Prog Urol Assunto da revista: UROLOGIA Ano de publicação: 2022 Tipo de documento: Article